Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Clinical trial NCT00043927 · COMPLETED

Trial details

NCT number: NCT00043927
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2001-04-01
Primary completion: 2004-01-01
Enrollment: 760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.